NO871352D0 - Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer. - Google Patents

Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.

Info

Publication number
NO871352D0
NO871352D0 NO871352A NO871352A NO871352D0 NO 871352 D0 NO871352 D0 NO 871352D0 NO 871352 A NO871352 A NO 871352A NO 871352 A NO871352 A NO 871352A NO 871352 D0 NO871352 D0 NO 871352D0
Authority
NO
Norway
Prior art keywords
human tumor
procedures
mixtures
identification
disclosed
Prior art date
Application number
NO871352A
Other languages
English (en)
Other versions
NO175642C (no
NO871352L (no
NO175642B (no
Inventor
Garth L Nicolson
Susan M North
Peter A Steck
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO871352D0 publication Critical patent/NO871352D0/no
Publication of NO871352L publication Critical patent/NO871352L/no
Publication of NO175642B publication Critical patent/NO175642B/no
Publication of NO175642C publication Critical patent/NO175642C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Stereophonic System (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Communication Control (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
NO871352A 1986-04-01 1987-03-31 Hovedsakelig rent humant tumor gp580 antigen, fremgangsmåte for fremstilling derav, antistoff mot dette, kontinuerlig hybrid cellelinje som produserer antistoffet og anvendelse av antistoffet ved in vitro diagnose NO175642C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,938 US5030559A (en) 1986-04-01 1986-04-01 Methods and compositions for the identification of metastatic human tumors

Publications (4)

Publication Number Publication Date
NO871352D0 true NO871352D0 (no) 1987-03-31
NO871352L NO871352L (no) 1987-10-02
NO175642B NO175642B (no) 1994-08-01
NO175642C NO175642C (no) 1994-11-09

Family

ID=25299361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871352A NO175642C (no) 1986-04-01 1987-03-31 Hovedsakelig rent humant tumor gp580 antigen, fremgangsmåte for fremstilling derav, antistoff mot dette, kontinuerlig hybrid cellelinje som produserer antistoffet og anvendelse av antistoffet ved in vitro diagnose

Country Status (11)

Country Link
US (1) US5030559A (no)
EP (1) EP0240341B1 (no)
JP (1) JPH0742320B2 (no)
AT (1) ATE105569T1 (no)
AU (1) AU599364B2 (no)
CA (1) CA1307478C (no)
DE (1) DE3789781T2 (no)
DK (1) DK162387A (no)
ES (1) ES2051737T3 (no)
FI (1) FI89806C (no)
NO (1) NO175642C (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE403802B (sv) * 1972-10-10 1978-09-04 Buchegger Masch Reinigung Anordning for rengoring och avfettning av maskindelar och liknande
US5646004A (en) * 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5648223A (en) * 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
DE19530272C1 (de) * 1995-08-17 1996-11-21 Univ Eberhard Karls Antikörper 103 B2
DE19530273C1 (de) * 1995-08-17 1996-12-12 Univ Eberhard Karls Antikörper 105A5
CA2429723A1 (en) * 2000-11-28 2002-06-06 Wyeth Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
AU2002236503C1 (en) * 2000-11-28 2008-11-13 Wyeth Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
CA2429722A1 (en) * 2000-11-28 2002-06-06 Wyeth Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7169722B2 (en) * 2002-01-28 2007-01-30 Guardian Industries Corp. Clear glass composition with high visible transmittance
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
CL2007002615A1 (es) * 2006-09-08 2008-04-18 Wyeth Corp Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US20090324596A1 (en) * 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
CA2839693A1 (en) * 2011-06-19 2012-12-27 Abogen, Inc. Devices, solutions and methods for sample collection
CN107430105A (zh) 2015-02-09 2017-12-01 阿波根有限公司 用于采集相关应用、分析和诊断的样本的设备、溶液和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
IN150740B (no) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
DE3586216T2 (de) * 1984-05-01 1992-12-10 Ciba Corning Diagnostics Corp Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.

Also Published As

Publication number Publication date
DE3789781D1 (de) 1994-06-16
FI89806B (fi) 1993-08-13
NO175642C (no) 1994-11-09
EP0240341A2 (en) 1987-10-07
DE3789781T2 (de) 1994-11-10
AU7075387A (en) 1987-10-08
NO871352L (no) 1987-10-02
US5030559A (en) 1991-07-09
FI871411A (fi) 1987-10-02
FI871411A0 (fi) 1987-03-31
AU599364B2 (en) 1990-07-19
JPS62253395A (ja) 1987-11-05
JPH0742320B2 (ja) 1995-05-10
DK162387D0 (da) 1987-03-31
FI89806C (fi) 1993-11-25
EP0240341A3 (en) 1989-07-19
ATE105569T1 (de) 1994-05-15
ES2051737T3 (es) 1994-07-01
DK162387A (da) 1987-10-02
NO175642B (no) 1994-08-01
CA1307478C (en) 1992-09-15
EP0240341B1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
NO871352D0 (no) Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.
EP0288082A3 (en) A tumor specific assay for ca125 ovarian cancer antigen
WO1999004265A8 (en) Cancer associated nucleic acids and polypeptides
FI854604A0 (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
WO2000036107A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
EP1630235A3 (en) Compounds for immunodiagnosis of prostate cancer and method for their use
EP0102381A4 (en) METHOD FOR IDENTIFYING AND CLEANING ANTIGENS (hLTAA) ASSOCIATED WITH HUMAN LUNG TUMOR AND CLINICALLY DETECTING AND DETERMINING THIS ANTIGENS.
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
EP0163303A3 (en) Human monoclonal antibodies to cell surface and intracellular antigens
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
JPS5386016A (en) Identification * diagnostic and immunological method for surface protein of cancer cell
CA2207505A1 (en) Neurological drug screens
NO960925D0 (no) Diagnostiske, prognostiske og terapeutiske metoder for faste, ikke-lymfoide tumorer og deres metastaser
SE8100011L (sv) Detektering av cancerceller
DK0454782T3 (da) Cancer-beslægtet haptaglobin (Hpr.)
CA2294514A1 (en) Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
AU2883597A (en) Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
ES8707863A1 (es) Un procedimiento para producir un anticuerpo monoclonal para carcinoma de pulmon humano de celulas no pequenas.
WO1991017187A3 (en) A 35kd tumor associated protein antigen: uses and methods of detection
DE3582191D1 (de) Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
ØRJASæTER STUDY OF SUBSTANCES RELATED TO CARCINOEMBRYONIC ANTIGENS, CEA‐NCA AND ASSOCIATION WITH α1‐ANTICHYMOTRYPSIN
NZ333075A (en) isolated protein markers for use in diagnosing esophageal cancer
AU5752490A (en) A novel tumor associated antigen
EP0272113A3 (en) Anti-human cancer monoclonal antibodies